PF-Atlas › Clinical Trials › NCT01793649

A Phase 1 Study to Characterize the Effect of GS-5737 Enhancement of Mucociliary Clearance in Healthy Subjects

GS-5737 · Phase 1

Registry ID

NCT01793649

Phase

Phase 1

Status

Terminated

Drug / intervention

GS-5737

Sponsor

Gilead Sciences

Start

2012-10

Enrollment

Locations

About this trial

This is a randomized, double-blind, cross-over, vehicle-controlled study to determine whether GS-5737 in 2.8% saline accelerates mucociliary clearance (MCC) in healthy subjects, compared to vehicle of 2.8% saline alone.

View NCT01793649 on ClinicalTrials.gov →

Explore related

All GS-5737 trials All IPF trials

Medical disclaimer. This page summarizes public trial data for NCT01793649 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.